Hoffmann-La Roche: all 2,744 studies
Page 21 of 28. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)TerminatedNCT01861444
- A Comparison of Continuous Bevacizumab (Avastin) Treatment or Placebo in Addition to Lomustine Followed by Standard of Care After Disease Progression in Participants With GlioblastomaCompletedNCT01860638Phase 2
- A Study of the Effect of Vemurafenib on the Pharmacokinetics of Acenocoumarol in Patients With BRAFV600 Mutation-Positive Metastatic MalignancyCompletedNCT01851824Phase 1
- FoundationOne™ Test Registry StudyCompletedNCT01851213
- A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic MalignancyCompletedNCT01849666Phase 1
- A Study on the Effect of Vemurafenib on the Pharmacokinetics of a Single Dose of Tizanidine in Patients With BRAFV600 Mutation-Positive Metastatic MalignanciesCompletedNCT01844674Phase 1
- A Non-Interventional Study of Treatment Pattern and Clinical Outcomes in Chinese Participants With Gastric CancerCompletedNCT01839500
- A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid ArthritisCompletedNCT01834807
- An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Cancer of the Colon or RectumCompletedNCT01830647
- AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the LungCompletedNCT01827852
- Study on Improvement of Blood Glucose Control in Patients With Diabetes Type 2 Using SMBGTerminatedNCT01820169Not applicable
- A Study of Single Dose Inclacumab in Japanese Healthy Volunteers Compared to Caucasian Healthy VolunteersCompletedNCT01815827Phase 1
- A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy VolunteersCompletedNCT01814709Phase 1
- A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 YearsCompletedNCT01810393Phase 3
- Safety Study of Olesoxime in Patients With Stable Relapsing Remitting Multiple Sclerosis Treated With Interferon Beta.CompletedNCT01808885Phase 1
- A Bioavailability and Pharmacokinetic Study of Subcutaneous and Intravenous RO6811135 in Healthy VolunteersCompletedNCT01802853Phase 1
- An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Ribavirin Based Regimens in Patients With Chronic Hepatitis C With Previous Treatment FailureTerminatedNCT01798576
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis B Who Have Failed Antiviral Treatment With Nucleoside (Nucleotide) AnaloguesTerminatedNCT01794234
- A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD)CompletedNCT01793441Phase 2
- BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal CancerCompletedNCT01791140
- An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer (GERTAC)CompletedNCT01790217
- A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes MellitusCompletedNCT01789788Phase 1
- BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian CancerCompletedNCT01788995
- HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin TherapyCompletedNCT01777958
- An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)CompletedNCT01775644
- A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment CharacteristicsCompletedNCT01775514
- A Study of RO5503781 as a Single Agent or in Combination With Cytarabine in Participants With Acute Myelogenous LeukemiaCompletedNCT01773408Phase 1
- A Drug-Drug Interaction Study of the Effect of Rabeprazole, Itraconazole or Fluconazole on the Pharmacokinetics of VismodegibCompletedNCT01772290Phase 1
- A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid ArthritisCompletedNCT01770834
- A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer ParticipantsCompletedNCT01767623Phase 1
- A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic MelanomaWithdrawnNCT01765556Phase 1
- A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)CompletedNCT01756612
- Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis PatientsCompletedNCT01755078Phase 4
- A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft RecipientsCompletedNCT01753167Phase 2
- A Study of RO4917523 in Pediatric Patients With Fragile X SyndromeCompletedNCT01750957Phase 2
- An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1CompletedNCT01750216
- A Study of Ritonavir-Boosted Danoprevir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients of Asian Origin With Chronic Hepatitis C Genotype 1 With or Without CirrhosisCompletedNCT01749150Phase 2
- A Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab With Chemoradiotherapy in the Adjuvant Setting in Operated Participants With Human Epidermal Growth Factor Receptor-2 Positive (HER2+) Gastric or Gastroesophageal Junction CancerCompletedNCT01748773Phase 2
- The Management of Schizophrenia in Clinical Practice (MOSAIC)CompletedNCT01746134
- A Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast CancerCompletedNCT01740336Phase 2
- A Study of Bevacizumab (Avastin) in Neoadjuvant Therapy in Participants With International Federation of Gynecology and Obstetrics (FIGO) Stage IIIC/IV Ovarian, Tubal, or Peritoneal Cancer, Initially UnresectableCompletedNCT01739218Phase 2
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis BCompletedNCT01734018
- The Mycophenolate Pregnancy RegistryCompletedNCT01733082
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis BCompletedNCT01730508
- A Long-Term Extension Study of RoActemra/Actemra (Tocilizumab) in Patients With Early Moderate to Severe Rheumatoid Arthritis Who Completed Study WA19926CompletedNCT01730456Phase 3
- A Study of The Effect of Aleglitazar on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With MetforminCompletedNCT01729403Phase 2
- An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 StudyCompletedNCT01727986Phase 3
- An Observational Study of MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in First-Line in Patients With Diffuse Large B-Cell LymphomaTerminatedNCT01724294
- ASPET Study: An Observational Study of Tarceva (Erlotinib) in First Line in Patients With Advanced Non-Small Cell Lung Cancer Harbouring EGFR Activating MutationsCompletedNCT01723878
- A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza InfectionCompletedNCT01715909Phase 1
- A Study on The Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With Stable Cardiovascular Disease and Glucose AbnormalitiesCompletedNCT01715818Phase 3
- A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy ControlsCompletedNCT01714154Phase 1
- An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal CancerCompletedNCT01712347
- A Study of Safety, Pharmacokinetics (Including Food Effect) And Pharmacodynamics of RO5545965 in Healthy VolunteersCompletedNCT01711801Phase 1
- A Pharmacokinetic Study of Aleglitazar in Healthy Chinese VolunteersCompletedNCT01711775Phase 1
- A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male VolunteersCompletedNCT01711762Phase 1
- A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy VolunteersCompletedNCT01708616Phase 1
- An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft RecipientsCompletedNCT01707550
- A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis BCompletedNCT01705704
- A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseWithdrawnNCT01702714Phase 1
- A Pharmacokinetics Study of Aleglitazar in Combination With Digoxin in Healthy VolunteersCompletedNCT01701739Phase 1
- A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy VolunteersCompletedNCT01701089Phase 1
- An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA)CompletedNCT01697488
- A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus TabletsCompletedNCT01697436Phase 1
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Sulfonylurea Alone or Sulfonylurea Plus Metformin TherapyCompletedNCT01691989Phase 3
- A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin AloneCompletedNCT01691846Phase 3
- A Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus Who Have Not Previously Received Anti-Hyperglycemic TherapyCompletedNCT01691755Phase 3
- An Observational Study of Mircera in Renal Anemia Correction In Dialysed Patients During Daily Clinical PracticeCompletedNCT01690455
- A Study of Vanucizumab (RO5520985) Alone or in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsCompletedNCT01688206Phase 1
- A Study of Venetoclax in Combination With Obinutuzumab in Participants With Chronic Lymphocytic LeukemiaCompletedNCT01685892Phase 1
- A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male VolunteersCompletedNCT01684891Phase 1
- An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's LymphomaCompletedNCT01684865
- A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery DiseaseCompletedNCT01680978Phase 2
- An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis CCompletedNCT01679834
- A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy VolunteersCompletedNCT01679639Phase 1
- An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer StudiesCompletedNCT01677780Phase 1
- A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyCompletedNCT01677754Phase 2
- An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS)CompletedNCT01676922
- A Study of Single Dose RO6811135 in Healthy VolunteersCompletedNCT01676584Phase 1
- An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS)CompletedNCT01674907
- A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD)CompletedNCT01674361Phase 2
- A Study of Venetoclax in Combination With Bendamustine + Rituximab or Bendamustine + Obinutuzumab in Participants With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia (CLL)CompletedNCT01671904Phase 1
- An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C InfectionCompletedNCT01671046
- A Non-Drug Study on the Relationship Between Exploratory Biomarkers and Functional Dimensions in Individuals With Autistic Disorder or Asperger's SyndromeCompletedNCT01669889
- An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab)CompletedNCT01667458
- An Observational Study of Mircera in Patients With Chronic Renal Anemia on Dialysis (CKD Stage V) or Not on Dialysis (CKD Stage III-IV)CompletedNCT01667380
- A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662CompletedNCT01667367Phase 1
- A Study of the Relative Bioavailability of Single Dose RO4917838 and the Effect of Food in Healthy VolunteersCompletedNCT01665976Phase 1
- A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy VolunteersCompletedNCT01665404Phase 1
- A Single-Center Study of RO5508887 in Healthy VolunteersCompletedNCT01664143Phase 1
- A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal CancerCompletedNCT01662869Phase 3
- An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast CancerCompletedNCT01661153
- PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung CancerCompletedNCT01659970
- A Phase 1b Study of Atezolizumab in Combination With Vemurafenib or Vemurafenib Plus Cobimetinib in Participants With BRAFV600-Mutation Positive Metastatic MelanomaCompletedNCT01656642Phase 1
- A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease PatientsCompletedNCT01656525Phase 1
- A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy VolunteersCompletedNCT01654211Phase 1
- Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)CompletedNCT01652482Phase 2
- A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)CompletedNCT01649817
- A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265CompletedNCT01645969
- A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)TerminatedNCT01643863